Eco Animal Health Group (LON:EAH)‘s stock had its “buy” rating reiterated by equities research analysts at Peel Hunt in a note issued to investors on Thursday.
Shares of EAH stock opened at GBX 382.50 ($5.00) on Thursday. Eco Animal Health Group has a fifty-two week low of GBX 485 ($6.34) and a fifty-two week high of GBX 680 ($8.89).
In other Eco Animal Health Group news, insider Anthony Paul Rawlinson sold 60,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 28th. The shares were sold at an average price of GBX 500 ($6.53), for a total transaction of £300,000 ($392,003.14).
Eco Animal Health Group Company Profile
ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
See Also: Exchange-Traded Funds (ETFs)
Receive News & Ratings for Eco Animal Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eco Animal Health Group and related companies with MarketBeat.com's FREE daily email newsletter.